News

Based on input received at the pre-new drug submission (NDS) meeting, the company believes that no additional pivotal clinical data beyond that which was submitted as part of

As part of the restructuring and in order to further reduce costs, president and CEO, James Burns, will be leaving the company and resigning from the board of

According to the company, the new Diazyme lithium assay provides improved reagent stability and a reduced cost per test. The assay features accuracy and precision and offers an

According to the company, Embozene microspheres are the first and only microspheres to be color-enhanced with a different color for each size for increased procedural safety, efficiency and

The company presented data from the Phase II trial of BSI-201 in metastatic breast cancer patients whose tumors were negative for three common breast cancer markers: estrogen receptor,

AmVac and the National Health Research Institutes in Taiwan have resolved to launch a joint collaboration with the aim of developing a new avian flu vaccine. The Taiwanese

Abraxane is an albumin-bound nanoparticle formulation of paclitaxel. In the European Union (EU), Abraxane is indicated for the treatment of metastatic breast cancer in patients who have failed

The investment includes the purchase of 100,000sqft of land adjacent to the current facility where the company intends to make further upgrades in the next three years. The

MDRNA’s generic calcitonin-salmon nasal spray is the generic equivalent of Miacalcin marketed by Novartis Pharmaceuticals. Full FDA approval would follow the completion of Apotex’s 180-day exclusivity period, or